Hereditary Angioedema Pipeline Holding Up Long-Term

(MedPage Today) — ORLANDO — Long-term results from trials of new drugs for hereditary angioedema (HAE) continue to support efficacy and safety, researchers reported at the American College of Allergy, Asthma & Immunology meeting.
“Long…